{
    "code": 0,
    "data": [
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call - Q3 - FY 2025-26",
            "news_id": "1463aa95-6fa0-4125-8196-a2c5d91d8430",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59f6ce31-d901-4d01-89b2-9ee265816dae.pdf",
            "news_date": "2026-02-11 21:24:42",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call - Q3 - FY 2025-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59f6ce31-d901-4d01-89b2-9ee265816dae.pdf",
            "news_date": "2026-02-11 21:24:42"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Results - Analyst/Investor Meet - Earnings Call - Q3(2025-2026) - Audio Recording",
            "news_id": "e63be24f-acac-4b72-aa67-a7fc80c2c4b3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6966d870-0ffb-4ba7-bb60-5c39b5536a83.pdf",
            "news_date": "2026-02-05 21:29:31",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Results - Analyst/Investor Meet - Earnings Call - Q3(2025-2026) - Audio Recording",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6966d870-0ffb-4ba7-bb60-5c39b5536a83.pdf",
            "news_date": "2026-02-05 21:29:31"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter and nine months ended December 31 2025",
            "news_id": "e14fe565-8695-4949-abc0-16e19c4b0abb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f761aa80-9ccc-4e05-9554-153ba6062c17.pdf",
            "news_date": "2026-02-05 14:22:14",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f761aa80-9ccc-4e05-9554-153ba6062c17.pdf",
            "news_date": "2026-02-05 14:22:14"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Unaudited standalone and Consolidated Financial Results for the Quarter and nine months ended December 31 2025",
            "news_id": "1fae70f4-d80e-4c54-8c76-b1c1a3b2d063",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cc91ea8-f706-4bfe-bca0-c849dfef634b.pdf",
            "news_date": "2026-02-05 13:21:59",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Unaudited standalone and Consolidated Financial Results for the Quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cc91ea8-f706-4bfe-bca0-c849dfef634b.pdf",
            "news_date": "2026-02-05 13:21:59"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of the Board Meeting held on February 05 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c673eda-29a4-4c2f-8b23-080fb131eb4a.pdf",
            "news_date": "2026-02-05 13:08:07"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Directors of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=829d8e3b-7aff-4c83-a484-53a59fc3110a.pdf",
            "news_date": "2026-02-03 15:23:26"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Voting results and Scrutinizer report for the Postal Ballot dated January 31 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bd8031a-9042-4981-aab3-942490f5a1a0.pdf",
            "news_date": "2026-02-03 14:55:54"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Analyst / investor Call for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3daee57c-ffe1-4ec0-ab2f-70772a04d509.pdf",
            "news_date": "2026-01-29 15:54:40"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release regarding receipt of final approval by our Subsidiary Caplin Steriles Limited from the USFDA for the ANDA Methylprednisolone Acetate Injectable Suspension USP.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9ea92dd-a2a8-4632-8e08-e434fdcec6fc.pdf",
            "news_date": "2026-01-27 15:28:24"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 inter alia to consider and approve the unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6c66d81-4157-4765-ab69-1834c16081be.pdf",
            "news_date": "2026-01-27 11:37:17"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d7d7d39-e530-4937-ac71-85e1497c73cb.pdf",
            "news_date": "2026-01-14 11:23:29"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Press Release On Acquisition Of Andas",
            "news_body": "Company had disseminated a press release containing information on acquisition of ten ANDAs from a Global generic manufacturing company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26fc1e20-b924-42d9-ad30-52e9671a1a65.pdf",
            "news_date": "2026-01-01 11:44:36"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading window commencing from January 01 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65c51053-0055-49ac-bc2d-4ed1ad11c7a8.pdf",
            "news_date": "2025-12-31 18:31:18"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "We enclose herewith the Notice of Postal Ballot of Caplin Point Laboratories Limited seeking the approval of members for the resolutions mentioned in the Notice.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3df9d4a8-713a-4cdc-96a8-c2bdbf5c9937.pdf",
            "news_date": "2025-12-31 15:24:47"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Completion Of Inspection By INVIMA-Colombia At The Puducherry Injectables Facility Of The Company",
            "news_body": "This is to inform you that INVIMA - Colombia conducted an inspection of the injectables facility of the Company located at Puducherry. The inspection was conducted between 8th December 2025 and 12th December 2025 and was completed successfully.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dbd85b96-c2f2-4963-af18-f95d07fde99d.pdf",
            "news_date": "2025-12-12 17:46:55"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Press Release On USFDA Approval",
            "news_body": "Press Release on the companys Subsidiary Caplin Steriles Limited getting USFDA approval for its ANDA Linezolid Injection 600 mg/ 300 mL (2 mg/mL) Single Dose Infusion Bags",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fe0883e-03ec-4d5f-887e-3d9674189f12.pdf",
            "news_date": "2025-12-09 13:57:31"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Press Release",
            "news_body": "Press Release regarding receipt of final approval by our Subsidiary Caplin Steriles Limited from USFDA for ANDA Acetaminophen Injection 1000 mg/100 mL (10 mg/ mL) single dose infusion bags.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c0e1996-788f-4a3d-87a4-120d18cae1bc.pdf",
            "news_date": "2025-12-08 15:36:30"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Acquisition Of Land By Subsidiary",
            "news_body": "Acquisition of land by Subsidiary at Mexico",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f943ab0c-4ba2-4cc6-a253-5795156a3056.pdf",
            "news_date": "2025-11-14 17:19:17"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call - Q2 & H1 FY 2025-26",
            "news_id": "b0d88c11-3666-4098-a9db-de2b9f526e27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92ae23d9-65c0-49a7-9615-ab1442f6a19d.pdf",
            "news_date": "2025-11-12 18:49:46",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call - Q2 & H1 FY 2025-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92ae23d9-65c0-49a7-9615-ab1442f6a19d.pdf",
            "news_date": "2025-11-12 18:49:46"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Results - Analyst/Investor Meet - Earnings Call - Q2(2025-2026) - Audio Recording",
            "news_id": "28aa6b09-09ed-4079-836c-42e5e68588eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d5205fe-6e49-4443-b824-043d16c7b5eb.pdf",
            "news_date": "2025-11-06 18:29:06",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Results - Analyst/Investor Meet - Earnings Call - Q2(2025-2026) - Audio Recording",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d5205fe-6e49-4443-b824-043d16c7b5eb.pdf",
            "news_date": "2025-11-06 18:29:06"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Directors of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc8ab874-3b8a-40e2-8d01-108c44768afa.pdf",
            "news_date": "2025-11-05 16:26:08"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Change in Senior Managerial Personnel of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6848b08c-f1b5-49c7-bd86-734a28a4975b.pdf",
            "news_date": "2025-11-05 16:23:34"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Un-audited standalone and consolidated financial results for the quarter and half year ended 30th September 2025",
            "news_id": "7eee53db-5a09-44e0-8d83-fabea655a89b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f886ccc-f499-4e93-899f-4995a326fff3.pdf",
            "news_date": "2025-11-05 13:49:33",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Un-audited standalone and consolidated financial results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f886ccc-f499-4e93-899f-4995a326fff3.pdf",
            "news_date": "2025-11-05 13:49:33"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Outcome of the Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac18a50c-39e3-4daa-8ae4-7d391546e00c.pdf",
            "news_date": "2025-11-05 13:41:13"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Half-Year Ended September 30 2025",
            "news_body": "Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 inter alia to consider and approve the unaudited financial results of the Company for the quarter and half-year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cb740df-e4f5-42c6-a558-08437e0a05a9.pdf",
            "news_date": "2025-10-29 19:12:13"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Analyst / investor Call for the quarter and half ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d626a357-d44d-4ba7-9e9c-b06b120ef8a3.pdf",
            "news_date": "2025-10-29 18:40:33"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approving Inter-Alia The Unaudited Financial Results Of The Company For The Quarter And Half-Year Ended September 30 2025",
            "news_body": "Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve unaudited financial results of the Company for the quarter and half-year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e68de70b-b264-416b-bd3b-6fb67a13a030.pdf",
            "news_date": "2025-10-29 18:33:21"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release - Receipt of USFDA approval and recent acquisition of third party ANDAs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e32b45d-23e4-4d0a-8222-cd3c2cda5ff6.pdf",
            "news_date": "2025-10-23 14:49:04"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e5135a4-aceb-4ee6-a789-c27b44166fe2.pdf",
            "news_date": "2025-10-04 14:03:13"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d73da2ae-9c84-40b3-bac3-443102017487.pdf",
            "news_date": "2025-09-29 16:44:49"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Voting Results and Scrutinizer Report for the 34th Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1dc62f4c-cc3f-41a7-bbd2-f7318958a7ce.pdf",
            "news_date": "2025-09-23 18:11:52"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Intimation of Appointment of Secretarial Auditor of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1541489-d1ff-443d-8ad6-6012b11b8f5d.pdf",
            "news_date": "2025-09-22 17:04:25"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings of 34th Annual General Meeting of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e99f0c87-c49d-4d5c-a196-1695eace7b81.pdf",
            "news_date": "2025-09-22 17:02:01"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press release - Receipt of USFDA Approval",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37dcee98-03c4-4c31-b26a-d66b7f1b7268.pdf",
            "news_date": "2025-09-03 13:58:56"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication on Notice of 34th Annual General Meeting of the Company along with e-voting information",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e1c67d0-5aa4-4869-9492-4350007cdecc.pdf",
            "news_date": "2025-09-01 16:58:32"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Reporting for the Financial Year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c980d7ba-778e-41c1-ac32-797090e2ce19.pdf",
            "news_date": "2025-08-30 16:31:01"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Notice Of 34Th Annual General Meeting Of The Company",
            "news_body": "Notice of 34th Annual General Meeting of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b543e988-fa9e-4511-b09e-6cc7b1d6d666.pdf",
            "news_date": "2025-08-30 16:29:00"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for the Financial Year ended March 31 2025 - Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=500e1647-d2c9-44c8-8ed7-06ba0d8af9cf.pdf",
            "news_date": "2025-08-30 16:25:25"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript",
            "news_id": "aa59217c-0789-4f5e-ad15-31405fdafe95",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85d773ee-a620-46ea-8f29-0c1a72cd2a3e.pdf",
            "news_date": "2025-08-14 17:36:41",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85d773ee-a620-46ea-8f29-0c1a72cd2a3e.pdf",
            "news_date": "2025-08-14 17:36:41"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Analyst/Earnings Call - Q1 FY 2025-26 - Recording",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b71c1884-74b0-41f7-9434-979f34af0cfd.pdf",
            "news_date": "2025-08-07 19:33:15"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Record date for the final dividend is on September 12 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f32849d7-31e5-482e-b02a-6466df26bf8c.pdf",
            "news_date": "2025-08-07 13:06:09"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Financial Results for the Quarter ended June 30 2025",
            "news_id": "bc51a6a6-d5ed-4ab3-bde0-ce03d99538d8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e18ffab4-fe29-41aa-a4b8-a235793e22bf.pdf",
            "news_date": "2025-08-07 13:00:25",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Financial Results for the Quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e18ffab4-fe29-41aa-a4b8-a235793e22bf.pdf",
            "news_date": "2025-08-07 13:00:25"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On August 7 2025",
            "news_body": "Outcome of the Board Meeting held on August 7 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9de29da-3157-46db-ac88-12c5c8d41c25.pdf",
            "news_date": "2025-08-07 12:54:56"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Post-results conference call with the analysts / fund houses / investors to be held on Thursday August 7 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52b02aaa-cfec-499c-9d44-fba5df26622e.pdf",
            "news_date": "2025-07-30 12:56:57"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Of Directors Of The Company Will Be Held On Thursday August 07 2025 To Consider Inter-Alia Board Of Directors Of The Company Will Be Held On Thursday August 07 2025 To Consider Inter-Alia",
            "news_body": "Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve 1) Quarterly unaudited financial results for the quarter ended June 30 2025 (both standalone & consolidated); \r\n2) Recommendation of Final Dividend for the FY 2024-25 for approval of shareholders; \r\n3) Convening the Annual General Meeting of the Company; and\r\n4) Fixation of record date for determining the eligibility of shareholders entitled for the Final Dividend.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65f352d9-ea1c-4bb0-b3b7-26422401bf69.pdf",
            "news_date": "2025-07-30 12:41:10"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Resignation of Senior Management Personnel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9be4760b-3f9b-421f-bf2b-0df60722006b.pdf",
            "news_date": "2025-07-18 18:12:32"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2025 is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3699ec49-ba1d-464b-a8fc-ecca8bbf5ebb.pdf",
            "news_date": "2025-07-03 12:09:30"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Details regarding the closure of trading window is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d7f29f9-db82-48a2-b6da-0dd550f96ad1.pdf",
            "news_date": "2025-06-27 18:10:33"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Details regarding the designation as Senior Management Personnel is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95a6fdc3-33da-457d-934a-18382237640b.pdf",
            "news_date": "2025-06-27 16:41:00"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Attached the Newspaper Advertisement relating to transfer of unclaimed dividend amount and equity shares of the company to the IEPF Account.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbe65ba2-b809-4a8d-a9f1-a388e8f2251d.pdf",
            "news_date": "2025-06-26 17:38:46"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Caplin Point Laboratories Limited informed that Caplin Point Far East Limited Hong Kong wholly owned subsidiary of the Company had executed Share Purchase Agreement dated June 03 2025 for acquiring the entire stake in Triwin Pharma S.A DE C.V.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eda8bed3-d20a-45b6-aafa-cd12e7bcadff.pdf",
            "news_date": "2025-06-04 13:09:31"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Pursuant to regulation 24(A) of SEBI Listing Regulations the Annual Secretarial Compliance Report for the year ended March 31 2025 is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fec60ce0-e9e8-4f1e-9be6-3769823ee3c1.pdf",
            "news_date": "2025-05-28 18:01:25"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The link for the transcript of the earnings call w.r.t financial performance of the company for the quarter and year ended March 31 2025 is enclosed.",
            "news_id": "6d6fbdf7-35b8-4d5b-8eb9-fd4b6c1b9111",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a6d4995-6214-474e-8082-2c97831b37a6.pdf",
            "news_date": "2025-05-22 19:27:52",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The link for the transcript of the earnings call w.r.t financial performance of the company for the quarter and year ended March 31 2025 is enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a6d4995-6214-474e-8082-2c97831b37a6.pdf",
            "news_date": "2025-05-22 19:27:52"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Details relating to Newspaper Advertisement of Financial Results for the quarter and year ended March 31 2025 is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2aa84718-4b76-4edf-a513-165e81e0f294.pdf",
            "news_date": "2025-05-16 14:55:23"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The recording of the earnings call is submitted herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9edc4eb2-4605-428c-9430-8066a5a7a6df.pdf",
            "news_date": "2025-05-15 19:39:08"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "The Board declared an interim dividend of Rs. 3.00 per share (150%). The details of the same is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a11075b-fc68-4ed6-a2fc-dc590c20ff55.pdf",
            "news_date": "2025-05-15 13:52:54"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "The Record Date For Declaration Of Interim Dividend Is Fixed At May 30 2025. The Details Of The Same Is Attached Herewith.",
            "news_body": "The record date for declaration of interim dividend is fixed at May 30 2025. The details of the same is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e41e7f4-5c70-4cb0-bbf2-68ef91478497.pdf",
            "news_date": "2025-05-15 13:49:56"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "The Board Had Approved Interim Dividend For The Year Ended 31-03-2025 Along With The Audited Results. The Details Of The Same Is Enclosed Herewith.",
            "news_body": "The Board had approved interim dividend for the year ended 31-03-2025 along with the audited results. The details of the same is attached herewith.",
            "news_id": "6d883ecf-c10b-4556-862e-17e09648b25b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=190e56ba-9111-43af-aeed-7d504b231382.pdf",
            "news_date": "2025-05-15 13:42:04",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "The Board Had Approved Interim Dividend For The Year Ended 31-03-2025 Along With The Audited Results. The Details Of The Same Is Enclosed Herewith.",
            "news_body": "The Board had approved interim dividend for the year ended 31-03-2025 along with the audited results. The details of the same is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=190e56ba-9111-43af-aeed-7d504b231382.pdf",
            "news_date": "2025-05-15 13:42:04"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for The Board Had Approved Interim Dividend For The Year Ended 31-03-2025 Along With The Audited Results. The Details Of The Same Is Enclosed Herewith.",
            "news_body": "The Board had approved interim dividend for the year ended 31-03-2025 along with the audited results. The details of the same is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c3d4915-7c98-4afd-8307-46443964def8.pdf",
            "news_date": "2025-05-15 13:24:36"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release regarding receipt of USFDA Approval is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=092234c5-96ac-4c3e-9830-5c8eab18723a.pdf",
            "news_date": "2025-05-14 11:04:56"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "The details of resignation of Senior Management Personnel is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72772154-d93d-4ada-b709-671dddd29795.pdf",
            "news_date": "2025-05-07 19:44:50"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Q4 post-results conference call invite is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=921f5dac-5091-4343-bff9-8f37e1de3ba5.pdf",
            "news_date": "2025-05-07 16:06:06"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Financial Results And Declaration Of Interim Dividend If Approved By The Board.",
            "news_body": "Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 inter alia to consider and approve Annual audited financial results of the Company for the year ended March 31 2025 (both standalone & consolidated) and declaration of Interim Dividend if any for the FY 2024-25 and fixation of record date for determining the eligibility of shareholders.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2eab4a8-9e89-4b32-ba32-f055b02e1bf7.pdf",
            "news_date": "2025-05-07 15:11:51"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release regarding receipt of USFDA Approval is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e285f2a-4dc6-40e6-a78e-e40b16d3f7c0.pdf",
            "news_date": "2025-04-23 10:45:12"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "The details of resignation of Senior Management Personnel is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0eede744-a759-49b3-95b8-e4c66d84ce89.pdf",
            "news_date": "2025-04-21 18:37:58"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31 2025 is enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=159617e6-7e28-4718-9b45-0a2a4de9b7a3.pdf",
            "news_date": "2025-04-03 17:58:24"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Caplin Point Laboratories Limited informed that the Board of Directors of Caplin Point Far East Limited Hong Kong a material subsidiary of the Company had approved the investment in Neoethicals Chile SpA.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a8b7a07-31c3-4869-bac7-785e8c347b1b.pdf",
            "news_date": "2025-04-02 15:40:00"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Cautionary Letter From NSE And BSE On March 28 2025",
            "news_body": "Enclosing a copy of cautionary e-mail received from National Stock Exchange of India Limited and BSE Limited with respect to the intimation of Schedule of Investors/ Analysts Meet/ Call on August 30 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a4139fc-5548-4840-848a-729b25de08f5.pdf",
            "news_date": "2025-03-29 18:32:16"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Details regarding the closure of trading window is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a183896-bb39-402e-8ca2-b232d1ff8370.pdf",
            "news_date": "2025-03-25 16:42:35"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release regarding receipt of USFDA Approval is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2b5d34d-c3ed-442c-bbdd-f6bf2a36536a.pdf",
            "news_date": "2025-02-26 10:42:06"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The link for the transcript of the earnings call w.r.t financial performance of the company for quarter and nine months ended 31-12-2024 is enclosed.",
            "news_id": "44001ad6-7273-4824-95d0-b417cb6789da",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19d2fba8-78fc-4ab9-9c22-0f03546300bc.pdf",
            "news_date": "2025-02-14 18:25:25",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The link for the transcript of the earnings call w.r.t financial performance of the company for quarter and nine months ended 31-12-2024 is enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19d2fba8-78fc-4ab9-9c22-0f03546300bc.pdf",
            "news_date": "2025-02-14 18:25:25"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Details relating to Newspaper Advertisement of Financial Results for the quarter and nine months ended December 31 2024 is attached herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd9db4cf-8a6d-4f58-905b-9a9a830d9156.pdf",
            "news_date": "2025-02-08 16:43:24"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The web link for the audio recording of the Earnings call Q3 2024-25 held today i.e. Friday February 02 2025 at 17:00 hrs is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ed204de-c25a-42e2-a459-66809ae93972.pdf",
            "news_date": "2025-02-07 19:14:58"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated Filing (Financial) for Unaudited Financial Results for the quarter and nine months ended December 31 2024 is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c8a1dde-0621-4aec-8dcb-1e7cbbdbd235.pdf",
            "news_date": "2025-02-07 18:45:31"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Board Meeting Outcome Of The Financial Results For The Quarter Ended December 31 2024",
            "news_body": "Financial Results along with the Limited Review Report Press Release and Investor PPT for the Quarter Ended December 31 2024 is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61c69266-1ccc-4e71-8534-49db1b570abc.pdf",
            "news_date": "2025-02-07 13:20:49"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended December 31 2024",
            "news_body": "Financial Results along with the Limited Review Report Press Release and Investor PPT for the quarter ended December 31 2024 is enclosed",
            "news_id": "3525b30b-d13b-4b7f-8a81-021d830581ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a36a095-8554-4c14-bde2-44c98430b9fd.pdf",
            "news_date": "2025-02-07 13:15:53",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter Ended December 31 2024",
            "news_body": "Financial Results along with the Limited Review Report Press Release and Investor PPT for the quarter ended December 31 2024 is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a36a095-8554-4c14-bde2-44c98430b9fd.pdf",
            "news_date": "2025-02-07 13:15:53"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release regarding receipt of USFDA Approval is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a3230d3-89c2-46a7-a78b-b858657e92c8.pdf",
            "news_date": "2025-02-05 11:08:53"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation regarding post-results conference call with the analysts / fund houses/ investors is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=719e05cf-6309-4246-abb6-e77b74759718.pdf",
            "news_date": "2025-01-31 15:57:44"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation For Considering And Approving Un-Audited Financial Results",
            "news_body": "CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve The un-audited financial results of the Company for the quarter and nine months ended December 31 2024 (both standalone & consolidated)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bde63d8-89d1-49d5-8b1a-ac0928375118.pdf",
            "news_date": "2025-01-31 14:29:50"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release regarding receipt of USFDA Approval is attached herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06ff7f44-47bd-46ce-824a-275886ab08a2.pdf",
            "news_date": "2025-01-17 12:10:22"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update",
            "news_body": "Press Release regarding receipt of Establishment Inspection Report is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c04fc133-47f1-4215-8c41-1bf62f1bab8c.pdf",
            "news_date": "2025-01-06 18:19:57"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under regulation 74(5) of SEBI (DP) Regulations 2018 for the QE December 31 2024 is enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4570290-c36a-4d19-aeb3-11baad589622.pdf",
            "news_date": "2025-01-03 18:05:23"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Details regarding the closure of trading window is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35d8ec83-8786-4fb7-8ae9-114db7125c22.pdf",
            "news_date": "2024-12-27 15:30:05"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Company Update",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release regarding grant of USFDA Approval is attached herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42c93037-cfc4-4ce2-9a5b-ee68e2efee45.pdf",
            "news_date": "2024-12-16 12:21:22"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Details of loss of share certificates are attached herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b27b1c40-4f12-4b18-9c8f-87949e0c4326.pdf",
            "news_date": "2024-12-12 11:12:39"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Details of the Analyst/Institutional Investor Meeting is attached herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e953af3-6825-4891-a3b8-198263b04ea0.pdf",
            "news_date": "2024-12-09 17:13:44"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Details of loss of share certificates are attached herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b69961e3-a8c5-44ff-a48c-5a4970fae691.pdf",
            "news_date": "2024-11-15 10:54:00"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The weblink for the transcript is enclosed",
            "news_id": "7c5e6be5-9a44-42fb-a71e-924a1d7c769f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57c926b7-b77f-4a99-a5ef-511782e4ad2d.pdf",
            "news_date": "2024-11-14 11:28:34",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Company Update",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The weblink for the transcript is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57c926b7-b77f-4a99-a5ef-511782e4ad2d.pdf",
            "news_date": "2024-11-14 11:28:34"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Company Update",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "Details relating to cessation of Mr. D Sathyanarayanan as an Independent Director is attached herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2528442-bd7c-4683-8adc-6dd97b83458f.pdf",
            "news_date": "2024-11-08 17:53:52"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Details relating to Newspaper Advertisement of Financial Results for the quarter and half year ended September 30, 2024 is attached herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d72d533-2848-41f2-be80-bcd51dc1718f.pdf",
            "news_date": "2024-11-08 16:15:19"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The weblink for the audio recording of the Earnings Call for Q2/ FY 2024-25 held today, i.e. Thursday, November 07, 2024 at 16:00 hrs is enclosed",
            "news_id": "2b83870f-f02d-48b4-8565-be38b340c034",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1356b0c9-6ee1-424c-b4e6-3967588ad2a8.pdf",
            "news_date": "2024-11-07 20:22:27",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The weblink for the audio recording of the Earnings Call for Q2/ FY 2024-25 held today, i.e. Thursday, November 07, 2024 at 16:00 hrs is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1356b0c9-6ee1-424c-b4e6-3967588ad2a8.pdf",
            "news_date": "2024-11-07 20:22:27"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financials Results For The Quarter And Half-Year Ended September 30, 2024",
            "news_body": "Financial results for the quarter and half-year ended September 30, 2024 is enclosed",
            "news_id": "e8df6afa-1bff-4180-947a-265a0a972ec5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=773cfcec-4a44-4ac6-bd97-eed10ae85c6a.pdf",
            "news_date": "2024-11-07 13:42:17",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Financials Results For The Quarter And Half-Year Ended September 30, 2024",
            "news_body": "Financial results for the quarter and half-year ended September 30, 2024 is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=773cfcec-4a44-4ac6-bd97-eed10ae85c6a.pdf",
            "news_date": "2024-11-07 13:42:17"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Financial Results For The Quarter And Half-Year Ended September 30, 2024",
            "news_body": "Financial Results for the quarter and half-year ended September 30, 2024 is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c18112f7-06b7-4ebc-bee4-c2c065a78754.pdf",
            "news_date": "2024-11-07 13:32:04"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation regarding post-results conference call with the analyst's / fund houses/ investors is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89c58c75-8ed3-4c6d-b5ce-ed87b5b40d18.pdf",
            "news_date": "2024-10-30 17:40:02"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting",
            "news_body": "CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2024 ,inter alia, to consider and approve Un-audited Financial Results of the Company for the quarter and half-year ended September 30, 2024 (both standalone and consolidated)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6465aa41-63ed-4ad1-be17-edcaedc0ecd7.pdf",
            "news_date": "2024-10-30 17:04:04"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Details of Loss of Share Certificates are attached herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fcdd058-7e15-454f-b934-5fa40e8fdfb1.pdf",
            "news_date": "2024-10-23 18:22:30"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "We submit herewith a Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018, received from RTA of the Company for the quarter ended September 30, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1385a6ee-68ee-411e-b817-a48f0d3d4eaa.pdf",
            "news_date": "2024-10-10 15:30:02"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer''s Report",
            "news_body": "The Voting results along with the scrutinizers report is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d3938ee-4e1a-40c7-8572-dc96bfff9139.pdf",
            "news_date": "2024-10-01 18:35:33"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "Company Update",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Details of appointment of Mr. R Vijayaraghavan as an Independent Director of the Company is attached herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cef6a0c-a693-4313-843c-3c2999a725fe.pdf",
            "news_date": "2024-09-30 18:26:15"
        },
        {
            "co_code": 4464,
            "bse_code": 524742,
            "isin": "INE475E01026",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Details of Proceedings of the Thirty Third Annual General Meeting of the Company is attached herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34bf59fc-9fd9-43ab-9676-4641de8fe4b5.pdf",
            "news_date": "2024-09-30 18:07:38"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call - Q1 -FY 2024-25 is attached",
            "news_id": "5a0f53dd-4561-413b-a3ee-e739e433eeae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4979a1d-2a6e-4a67-8d44-bdf01abd7ba1.pdf",
            "news_date": "2024-08-14 19:05:30",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "The financial results for the quarter ended June 30, 2024 and the other items are enclosed",
            "news_id": "24660afe-3f1c-47c0-9e35-5397866b088b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e2a9dee-61f9-43e2-b1a8-8d636de71fb7.pdf",
            "news_date": "2024-08-07 13:05:15",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call held on May 16, 2024 is enclosed.",
            "news_id": "588b5e2a-b92c-43e7-9fe8-aa79a086686b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39c6f2a7-ef05-474f-8415-5d6f69a0e7ee.pdf",
            "news_date": "2024-05-23 19:02:14",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter And Year Ended March 31, 2024",
            "news_body": "The results for the quarter and year ended March 31, 2024 along with the details of interim divided is attached herewith",
            "news_id": "7306c1d5-1e03-4df5-a9d6-ffc4d6c6155a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6da851a4-d027-43af-a02e-8dce67d34fec.pdf",
            "news_date": "2024-05-16 13:55:17",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The link for the transcript of the earnings call w.r.t to the financial performance of the company for quarter and 9 months ended 31-12-2023 is enclosed.",
            "news_id": "57f7ee2f-8ba3-43a4-8ec4-fef9851cd980",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59a72a95-6a56-4e14-8e8d-b2853d4f0ff7.pdf",
            "news_date": "2024-02-16 17:51:48",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Website link for Audio recordings of investor meeting/ Investor call is enclosed",
            "news_id": "ff937d72-023b-42e9-a845-c3f7d2eb7516",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93f51f85-f9be-4985-9315-f6c8948e0c59.pdf",
            "news_date": "2024-02-09 19:19:35",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended December 31, 2023",
            "news_body": "Financial Results along with the Limited Review Report, Press Release and Investor PPT for the quarter ended December 31, 2023 is enclosed",
            "news_id": "17a4ff3e-7595-4184-9cfc-4215bb4de592",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=420c65a2-0c0c-4243-87c5-1f4d961e83b9.pdf",
            "news_date": "2024-02-09 12:46:32",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript is enclosed",
            "news_id": "6ad54af8-6fbd-4987-8553-e95d50b6f1d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f20335a2-022f-4754-bfa2-f87ef5d2c5a7.pdf",
            "news_date": "2023-11-17 22:08:36",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation to our communication dated November 03, 2023, we would like to update that the audio recording of the Earnings Call for Q2/ FY 2023-24 held today, i.e. Thursday, November 09, 2023 at 17:30 hrs (IST) has been made available on the Company's website.",
            "news_id": "51f9e0ab-ca0f-4383-8ff1-52100980832e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6c16153-5659-4c1b-b2aa-11283037ddc5.pdf",
            "news_date": "2023-11-09 22:16:06",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation to our communication dated November 03, 2023, we would like to update that the audio recording of the Earnings Call for Q2/ FY 2023-24 held today, i.e. Thursday, November 09, 2023 at 17:30 hrs (IST) has been made available on the Company's website.",
            "news_id": "5c1f8cf4-3b54-41f1-a1fe-916939abfc7f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=410388fa-981d-4c3e-a6a7-279664f582ef.pdf",
            "news_date": "2023-11-09 22:12:51",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "September 30, 2023",
            "news_body": "Financial Results for QE 30-09-2023, press release and Investor presentation is attached",
            "news_id": "ee0e4ac7-6cf5-47da-9d53-a5d4905e07dc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf4912e5-1a2a-490b-8836-04176b419bb5.pdf",
            "news_date": "2023-11-09 12:43:34",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "As Enclosed",
            "news_id": "e53d49c8-75b0-4979-b8bd-48142664bd1e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42019028-37f4-407f-a8b5-3064e379ab30.pdf",
            "news_date": "2023-08-16 21:07:37",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "As enclosed",
            "news_id": "0f53b836-d9ea-4c32-89d1-bbf3bc848f2e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8e8f313-d883-450c-9863-e3513856feaf.pdf",
            "news_date": "2023-08-16 21:02:32",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation to our communication dated August 03, 2023, we would like to update that the audio recording of the Earnings Call for Q1/ FY 2023-24 held today, i.e. Tuesday, August 08, 2023 at 11:00 hrs (IST) has been made available on the Company's website",
            "news_id": "9a4f1d97-09f8-4d99-94ca-f3a06ec67e7f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26b8d666-ebc8-4652-be1e-4c7e6553849b.pdf",
            "news_date": "2023-08-08 17:59:05",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Results and Final Dividend.",
            "news_id": "9cb736b9-e16d-48da-8504-d073086318ec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20775b84-8843-45b2-b130-3262c31f9b24.pdf",
            "news_date": "2023-08-07 13:53:28",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our letter dated May 22, 2023 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the transcript of the presentation made on Saturday, May 27, 2023, on audited Financial Results (Consolidated and Standalone) of the Company for the quarter and year ended March 31, 2023, is available on the Company's website",
            "news_id": "998237f4-e0fc-47ca-a3e7-5b69e75e6ef3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfaea454-05da-4ebf-8982-b65343bcda1e.pdf",
            "news_date": "2023-06-02 19:26:13",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Results - Analyst/Investor Meet - Earnings Call - Q4 - Audio Recording",
            "news_id": "f9ba4802-7bcc-4e03-bcef-e7465977059d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41f58b6f-82a1-4cb5-af0a-b317e76756cb.pdf",
            "news_date": "2023-05-27 18:38:58",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Year Ending March 31, 2023 Along With Auditors Report",
            "news_body": "we wish to inform you that the Board of Directors, at its meeting held today, has, inter-alia, approved the following:<BR> <BR> 1. Declared an Interim Dividend of INR. 2 (100 %) per equity share of face value of INR. 2 each for the financial year ended March 31, 2023.<BR> 2. Fixed June 9, 2023 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend.<BR> 3. Approved the Audited standalone and consolidated financial results (Annexure-1) of the Company as per Indian Accounting Standards for the year ending March 31, 2023 along with Auditors Report (Annexure - 2). We also enclose a Press Release issued by the Company (Annexure 3) and an investor presentation in this regard (Annexure 4).<BR> 4. Further the Nomination and Remuneration Committee of the Board of Directors of the Company, has allotted 12,000 equity shares of face value Rs. 2/- each, to the employees of the Company, upon exercise of stock options under Employee Stock Options Scheme(s) of the Company. <BR>",
            "news_id": "9198809e-fca7-43fa-ba3c-c11c15e74c1b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d4e5988-ff97-4272-83ba-19a911bf07e2.pdf",
            "news_date": "2023-05-27 12:43:30",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "we wish to inform you that the Board of Directors, at its meeting held today, has, inter-alia, approved the following:<BR> <BR> 1. Declared an Interim Dividend of INR. 2 (100 %) per equity share of face value of INR. 2 each for the financial year ended March 31, 2023.<BR> 2. Fixed June 9, 2023 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend.<BR> 3. Approved the Audited standalone and consolidated financial results (Annexure-1) of the Company as per Indian Accounting Standards for the year ending March 31, 2023 along with Auditors Report (Annexure - 2). We also enclose a Press Release issued by the Company (Annexure 3) and an investor presentation in this regard (Annexure 4).<BR> 4.Further the Nomination and Remuneration Committee of the Board of Directors of the Company, has allotted 12,000 equity shares of face value Rs. 2/- each, to the employees of the Company, upon exercise of stock options under Employee Stock Options Scheme(s) of the Company. <BR>",
            "news_id": "4094f8b9-4f27-454b-9b85-2e14e03fcb9d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1eaa7e59-64ec-4af2-b7e5-8ac1a3170192.pdf",
            "news_date": "2023-05-27 12:38:26",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended December 31, 2022",
            "news_body": "Further to our intimation dated January 28, 2023 we wish to inform you that the Board of Directors of the Company at its meeting held today has, inter-alia approved the Un-audited standalone and consolidated financial results and the Limited Review Report (Annexure-1) of the Company as per Indian Accounting Standards for the quarter and nine months ended December 31, 2022. We also enclose a Press Release issued by the Company (Annexure 2) and an investor presentation in this regard (Annexure 3).",
            "news_id": "537a74a8-b06a-40b3-af5f-9d51bcbac1e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92e4f686-6b42-461f-8009-4d1c5dc7c1a3.pdf",
            "news_date": "2023-02-11 13:32:42",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On February 11, 2023",
            "news_body": "Further to our intimation dated January 28, 2023 we wish to inform you that the Board of Directors of the Company at its meeting held today has, inter-alia approved the Un-audited standalone and consolidated financial results and the Limited Review Report (Annexure-1) of the Company as per Indian Accounting Standards for the quarter and nine months ended December 31, 2022. We also enclose a Press Release issued by the Company (Annexure 2) and an investor presentation in this regard (Annexure 3).",
            "news_id": "0f3e410b-5649-4ec5-97eb-436768cad44e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5b2dbd8-d76a-48b3-9a76-8b5c1a2601d3.pdf",
            "news_date": "2023-02-11 13:28:50",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions for the half year ended September 30, 2022. You are requested to take the above on record .",
            "news_id": "e3237222-3a46-4a8d-983a-ecfd197abd2a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7351f2c-1666-43b4-b3e7-9821ca2896b7.pdf",
            "news_date": "2022-11-27 22:35:04",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results  For Quarter And Half-Year Ended September 30, 2022",
            "news_body": "Un-audited standalone and consolidated financial results  for quarter and half-year ended September 30, 2022",
            "news_id": "ee533a08-dbba-4b3c-b536-1c9d8640cfe6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af857f9a-aabb-449a-9cfc-49f0f0997396.pdf",
            "news_date": "2022-11-12 13:46:11",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "365543d3-c7b3-4936-bc58-af267c437e5d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc41489c-ced1-4512-af60-8a094f41c370.pdf",
            "news_date": "2022-08-05 13:06:40",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "ff39c753-db98-4fc9-bbdc-58388b8add1a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43b2e504-9b0f-4b72-9e85-dfb74d2eb857.pdf",
            "news_date": "2022-06-02 15:22:31",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Results - Analyst/Investor Meet - Earnings Call - Q4 - Audio Recording",
            "news_id": "5b4883fa-64b7-41dd-87c3-b9d7d7f698ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f4b1e2c-749b-4ac4-8073-a1efebb7d9c0.pdf",
            "news_date": "2022-05-12 17:53:38",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting -",
            "news_body": "1. Declared an Interim Dividend of Rs. 2/- (100 %) per equity share of Rs.2 each for the financial year ended March 31, 2022.<BR> 2. Fixed 24th May 2022 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend.<BR> 3. Approved the Audited standalone and consolidated financial results (Annexure-1) of the Company as per Indian Accounting Standards for the year ending March 31, 2022 along with Auditors Report (Annexure - 2). We also enclose a Press Release issued by the Company (Annexure 3) and an investor presentation in this regard (Annexure 4).",
            "news_id": "596c3335-0257-4c5d-94db-5d83706e5fcf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf50f672-3eb2-4338-92fb-b378c23d3e4c.pdf",
            "news_date": "2022-05-12 13:03:06",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For The Quarter And Nine Months Ended December 31, 2021.",
            "news_body": "Further to our intimation dated January 28, 2022, we wish to inform you that the Board of Directors of the Company at its meeting held today has, inter-alia approved the Un-audited standalone and consolidated financial results and the Limited Review Report (Annexure-1) of the Company as per Indian Accounting Standards for the quarter and nine months ended December 31, 2021. We also enclose a Press Release issued by the Company (Annexure 2) and an investor presentation in this regard (Annexure 3).<BR> <BR> The meeting commenced at 11:00 A.M and concluded at 12:45 P.M.<BR> <BR> Kindly take the same on your records.<BR> <BR>",
            "news_id": "04114dd0-0f9f-4820-935b-0297b62053cd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44581acd-0ea9-49a3-b9df-d8f95d05cf93.pdf",
            "news_date": "2022-02-03 13:02:43",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Six Months Ended September 30, 2021.",
            "news_body": "Unaudited Standalone and Consolidated Financial Results for the quarter and six months ended September 30, 2021.",
            "news_id": "9f11abac-1ca3-4685-a821-f24f0ca38a5f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3797fad6-7930-4f6d-91c9-371df60d37ab.pdf",
            "news_date": "2021-11-02 12:56:34",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Compliance under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "1da67cf1-d73c-46a5-a001-7acdfd080cd3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30f8d312-3f19-490f-b564-5eec109e3ae3.pdf",
            "news_date": "2021-10-30 15:59:22",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approved The Un-Audited Standalone And Consolidated Financial Results And The Limited Review Report Of The Company As Per Indian Accounting Standards For The Quarter Ending 30Th June, 2021.",
            "news_body": "Approved the Un-audited standalone and consolidated financial results and the Limited Review Report of the Company as per Indian Accounting Standards for the quarter ending 30th June, 2021.",
            "news_id": "b5a6b0ed-65ac-4cfc-b9d1-8b2a5e56cb80",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=472350cf-bfce-46ce-81a0-d39f6b8d5fd3.pdf",
            "news_date": "2021-08-05 12:38:51",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "54e8a475-507c-4b6e-80f9-2e2021d2bdfc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da9b67e2-3d8c-4b26-bc91-f174ef9bd459.pdf",
            "news_date": "2021-08-05 12:27:42",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "2ba1a408-29dc-4a73-b3ea-21e86cfbb6f6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73452d73-1922-43f4-846a-18cde9dfc314.pdf",
            "news_date": "2021-06-04 14:25:40",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "71a8d6ee-2ec4-404a-b19e-d4079707d3b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cefe864-dbb0-4bdf-b400-b51d421e5ed0.pdf",
            "news_date": "2021-05-06 13:06:34",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "770237d9-a8b8-4242-8551-d19c6fe8e7b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a3fee06-9961-42b3-8f05-a9adfe7233f1.pdf",
            "news_date": "2021-05-06 13:02:39",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}